High - but not standard-dose atorvastatin prevents the increase of plasma matrix metalloproteinase-2 triggered by acute coronary syndromes

MeSH terms

• Acute Coronary Syndrome* / blood
• Acute Coronary Syndrome* / drug therapy
• Aged
• Atorvastatin* / administration & dosage
• Biomarkers / blood
• Female
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors* / administration & dosage
• Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
• Male
• Matrix Metalloproteinase 2* / blood
• Matrix Metalloproteinase 2* / metabolism
• Middle Aged
• Treatment Outcome